SEPTInvestingStart Free

OLMA 10-Q: SEC filing

Olema Pharmaceuticals

Filed with the SEC on · accession 0001193125-26-454421

OLMA filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. Olema Pharmaceuticals filed its quarterly 10-Q report for Q3 2026, disclosing routine financial results, cash position, and ongoing clinical development activities. The stock moved -1.8% by the first close after the filing.

Summary of the filing

Olema Pharmaceuticals filed its quarterly 10-Q report for Q3 2026, disclosing routine financial results, cash position, and ongoing clinical development activities. The filing includes details on financing arrangements, including an at-the-market offering program and a senior secured loan facility.

For details, click here →How to read a 10-Q →

Key details

FilerOlema Pharmaceuticals, Inc.
Sales agent for at-the-market offeringCowen and Company LLC
Sales agent for at-the-market offeringTD Securities LLC
Collaboration partnerNovartis
Collaboration partnerAurigene

How OLMA stock reacted

Close before

$7.36

Nov 9, 2026

First close after

-1.83%

$7.22

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for OLMA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for OLMA?

Click here

Frequently asked questions

What did OLMA file with the SEC on Nov 10, 2026?

OLMA filed a 10-Q (SEC filing). Olema Pharmaceuticals filed its quarterly 10-Q report for Q3 2026, disclosing routine financial results, cash position, and ongoing clinical development activities. The filing includes details on financing arrangements, including an at-the-market offering program and a senior secured loan facility.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did OLMA stock react to this filing?

OLMA closed at $7.36 before the filing and $7.22 on Nov 10, 2026 (-1.83%).

Other OLMA SEC filings

Get alerts when OLMA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
OLMA overviewOLMA analysisOLMA newsLatest SEC filings